![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CADL market cap is 218.18M. The company's latest EPS is USD -1.1825 and P/E is -5.67.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -9.63M | -9.58M | -8.86M | -10.32M | -7.9M |
Net Income | -8.8M | -9.61M | -8.44M | -11.1M | -8.22M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 125k | 125k | 0 |
Operating Income | -25.73M | -34.72M | -38.39M |
Net Income | -36.12M | -18.79M | -37.94M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Total Assets | 67.24M | 58.71M | 50.06M | 41.2M | 31.22M |
Total Liabilities | 27.59M | 27.94M | 27.04M | 28.46M | 25.24M |
Total Equity | 39.65M | 30.77M | 23.02M | 12.75M | 5.98M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 89.21M | 77.69M | 41.2M |
Total Liabilities | 25.07M | 29.98M | 28.46M |
Total Equity | 64.14M | 47.71M | 12.75M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | |||
Operating | -10.82M | -18.01M | -26.82M | -34.24M | -8.44M |
Investing | 19k | -150k | -253k | -280k | -7k |
Financing | N/A | N/A | N/A | -121k | -1.26M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Operating | -22.22M | -31.42M | -34.24M |
Investing | -1.84M | -1.3M | -280k |
Financing | 71.8M | 19.97M | -121k |
Market Cap | 218.18M |
Price to Earnings Ratio | -5.67 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 6.07 |
Price to Book Ratio | 16.87 |
Dividend Yield | - |
Shares Outstanding | 32.08M |
Average Volume (1 week) | 232.88k |
Average Volume (1 Month) | 321.24k |
52 Week Change | -37.61% |
52 Week High | 14.33 |
52 Week Low | 0.66 |
Spread (Intraday) | 0.34 (4.86%) |
Company Name | Candel Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.candeltx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions